KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Minority Interest (2016 - 2023)

Biogen (BIIB) has 15 years of Minority Interest data on record, last reported at -$4.1 million in Q3 2023.

  • For Q3 2023, Minority Interest changed N/A year-over-year to -$4.1 million; the TTM value through Sep 2023 reached -$4.1 million, changed N/A, while the annual FY2022 figure was -$9.5 million, 114.96% down from the prior year.
  • Minority Interest reached -$4.1 million in Q3 2023 per BIIB's latest filing, up from -$6.4 million in the prior quarter.
  • Across five years, Minority Interest topped out at $462.9 million in Q2 2021 and bottomed at -$21.6 million in Q1 2022.
  • Average Minority Interest over 5 years is $56.3 million, with a median of -$7.9 million recorded in 2019.
  • Peak YoY movement for Minority Interest: tumbled 375.61% in 2020, then skyrocketed 3327.14% in 2021.
  • A 5-year view of Minority Interest shows it stood at -$4.1 million in 2019, then crashed by 246.34% to -$14.2 million in 2020, then skyrocketed by 547.18% to $63.5 million in 2021, then tumbled by 114.96% to -$9.5 million in 2022, then surged by 56.84% to -$4.1 million in 2023.
  • Per Business Quant database, its latest 3 readings for Minority Interest were -$4.1 million in Q3 2023, -$6.4 million in Q2 2023, and -$9.6 million in Q1 2023.